Machine learning based identification potential feature genes for prediction of drug efficacy in nonalcoholic steatohepatitis animal model.
Journal:
Lipids in health and disease
PMID:
39182075
Abstract
BACKGROUND: Nonalcoholic Steatohepatitis (NASH) results from complex liver conditions involving metabolic, inflammatory, and fibrogenic processes. Despite its burden, there has been a lack of any approved food-and-drug administration therapy up till now.